Coronavirus World Map: 2,954,222 Confirmed Cases; 207 Countries; 202,597 Deaths

Note: There is now a newer Novel Coronavirus (COVID-19) Situation Report 100.

WHO Novel Coronavirus (COVID-19) Situation Report 99

• WHO has published the ‘R&D Blueprint: COVID-19 Experimental Treatments,’ which lists drug and non-drug experimental treatments for COVID-19. This can be found here.
• WHO has called on countries to ensure that usual immunization is maintained wherever possible and surveillance for vaccine-preventable diseases is not disrupted during the ongoing pandemic.
• WHO Director-General Dr. Tedros, in his regular media briefing yesterday, highlighted “As lockdowns in Europeease with declining numbers of new cases, we continue to urge countries to find, isolate, test and treat all cases of COVID-19 and trace every contact, to ensure these declining trends continue.”
• WHO continues to source millions of dollars of medical equipment and supplies to help Member States access global markets, which are overwhelmed by unprecedented demand. WHO is also supporting design and installation of COVID-19 treatment centers in a number of countries. For more, see ‘Subject in Focus’ below.

Risk Assessment

Global Level: Very High

Coronavirus Situation in Numbers

Globally

• 2,954,222 confirmed cases (76,026 new)
• 202,597 deaths (3,932 new)

European Region

• 1,386,693 confirmed cases (27,313 new)
• 126,429 deaths (1,904 new)

Regions of the Americas

• 1,179,607 confirmed cases (39,087 new)
• 60,211 deaths (1,722 new)

Eastern Mediterranean Region

• 171,238 confirmed cases (5,305 new)
•  7,148 deaths (157 new)

Western Pacific Region

• 145,385 confirmed cases (1,264 new)
• 5,998 deaths (40 new)

South-East Asia

• 48,348 confirmed cases (2,288 new)
• 1,917 deaths (93 new)

African Region

• 22,239 confirmed cases (769 new)
• 881 deaths (16 new)

SUBJECT IN FOCUS: Operations Support and Logistics (OSL) update

Sourcing Supplies – Progress Update

WHO and partners continue to work with suppliers to secure commitments for supplies needed for the COVID-19 response in countries with limited means to access markets for personal protective equipment, diagnostic testing supplies and clinical care equipment.

Adiagnosticpurchasing consortium, established by WHO to negotiate with manufacturers to address market shortages of diagnostic tests and supplies, has secured commitment for five million tests to be procured over the next four weeks. WHO continues to look for suppliers who can provide sample collection kits to increase overall procurement stocks.

Collective UN efforts to source extremely limited supplies of clinical equipment are ongoing. WHO and consortium partners have conducted market mapping activities to identify supply sources for oxygen concentrators, ventilators, and other essential equipment for COVID-19 treatment centers. To date, approximately US$400 million in clinical care equipment has been identified from oxygen production, biomedical equipment, and accessories manufacturers.

Discussions with private sector partners indicate manufacturers are generally in favor of the COVID-19 Supply Chain approach to sourcing and allocating supplies. This should bring clarity and transparency to requests for critical supplies that manufacturers are receiving from around the world.

Sourcing activities for personal protective equipment are ongoing. The first batch of purchases is expected to be placed for 75 million masks, 50 million respirators, 28 million gloves and 10 million face shields.

Discussions are ongoing with the Jack Ma Foundation for an additional provision of 100 million surgical masks and one million respirators.

Technical support for COVID-19 treatment centers

WHO is supporting Italy’s Bologna and Puglia provinces, helping to design and install COVID-19 treatment centers in these provinces’ hospitals. In Nigeria, WHOhasprovidedtechnicalguidanceforaproposedself-quarantine facility in an internally displaced persons (IDP) camp run by the International Organization for Migration (IOM). WHO has also provided support for the installation of COVID-19 treatment facilities in Burkina Faso, Côte d’Ivoire, Senegal, São Tomé and Príncipe and Australia.

Countries, territories or areas with reported laboratory-confirmed COVID-19 cases and deaths, April 28, 2020

Country/Territory/Area	Confirmed Cases
United States of America	960916
Spain	209465
Italy	199414
United Kingdom	157153
Germany	156337
France	127008
Turkey	112261
Russian Federation	93558
Iran	91472
China	84347
Brazil	61888
Canada	47316
Belgium	46687
Netherlands	38245
India	29435
Switzerland	29081
Peru	27517
Portugal	24027
Ecuador	23240
Ireland	19648
Sweden	18926
Saudi Arabia	18811
Israel	15466
Austria	15256
Mexico	14677
Pakistan	13915
Chile	13813
Singapore	13624
Japan	13576
Belarus	12208
Poland	11902
Romania	11339
Qatar	11244
United Arab Emirates	10839
Republic of Korea	10752
Ukraine	9410
Indonesia	9096
Denmark	8698
Serbia	8275
Philippines	7777
Norway	7533
Czechia	7449
Australia	6725
Dominican Republic	6293
Bangladesh	5913
Malaysia	5820
Panama	5779
Colombia	5379
South Africa	4793
Finland	4695
Egypt	4782
Morocco	4120
Argentina	3892
Luxembourg	3729
Algeria	3517
Republic of Moldova	3481
Kuwait	3288
Kazakhstan	2982
Thailand	2938
Bahrain	2723
Hungary	2649
Greece	2534
Oman	2131
Croatia	2039
Uzbekistan	1924
Armenia	1867
Iraq	1847
Iceland	1792
Afghanistan	1703
Azerbaijan	1678
Estonia	1647
Cameroon	1621
Bosnia and Herzegovina	1564
Ghana	1550
Lithuania	1449
Slovenia	1407
North Macedonia	1399
Puerto Rico	1389
Slovakia	1381
Cuba	1389
Bulgaria	1363
Nigeria	1337
Côte d’Ivoire	1164
Guinea	1163
New Zealand	1124
Djibouti	1035
Tunisia	967
Bolivia	950
Cyprus	822
Latvia	818
Kosovo	780
Andorra	748
Albania	736
Senegal	735
International (Diamond Princess Cruise Ship)	712
Lebanon	710
Kyrgyzstan	708
Niger	701
Costa Rica	695
Honduras	661
Burkina Faso	632
Uruguay	606
San Marino	538
Sri Lanka	523
Georgia	511
Guatemala	500
Somalia	480
Democratic Republic of the Congo	471
Malta	450
Jordan	449
Mayotte	433
Réunion	417
Mali	408
Kenya	363
Palestinian Territory	342
Mauritius	334
Venezuela	325
El Salvador	323
Montenegro	321
Isle of Man	308
Jamaica	305
United Republic of Tanzania	300
Jersey	281
Sudan	275
Vietnam	270
Equatorial Guinea	258
Guernsey	247
Paraguay	228
Maldives	214
Congo	207
Rwanda	207
Faroe Islands	187
Gabon	176
Martinique	175
Guadeloupe	149
Myanmar	146
Gibraltar	141
Brunei Darussalam	138
Guam	138
Liberia	133
Madagascar	128
Ethiopia	124
Cambodia	122
Trinidad and Tobago	116
French Guiana	111
Bermuda	109
Cabo Verde	106
Aruba	100
Monaco	98
Sierra Leone	99
Togo	99
Zambia	89
Liechtenstein	83
Barbados	79
Bahamas	80
Uganda	79
Mozambique	76
Guyana	74
Haiti	74
Sint Maarten	74
Guinea-Bissau	73
Cayman Islands	70
Eswatini	65
Benin	64
Libya	61
United States Virgin Islands	59
French Polynesia	58
Nepal	52
Chad	46
Syrian Arab Republic	43
Central African Republic	42
Eritrea	39
Mongolia	38
Saint Martin	38
Malawi	36
Zimbabwe	31
Angola	27
Antigua and Barbuda	24
Timor-Leste	24
Botswana	22
Lao People’s Democratic Republic	19
Belize	18
Fiji	18
Grenada	18
New Caledonia	18
Curaçao	16
Dominica	16
Namibia	16
Burundi	15
Saint Kitts and Nevis	15
Saint Lucia	15
Saint Vincent and the Grenadines	15
Northern Mariana Islands	14
Falkland Islands (Malvinas)	13
Nicaragua	13
Turks and Caicos	12
Greenland	11
Montserrat	11
Seychelles	11
Gambia	10
Suriname	10
Holy See	9
Papua New Guinea	8
São Tomé and Príncipe	8
Bhutan	7
Mauritania	7
Bonaire, Sint Eustatius and Saba	6
British Virgin Islands	6
Saint Barthelemy	6
South Sudan	6
Anguilla	3
Saint Pierre and Miquelon	1
Yemen	1
Total	2,954,222

14423​

Recommendations and Advice for the Public

If you are not in an area where COVID-19 is spreading or have not traveled from an area where COVID-19 is spreading or have not been in contact with an infected patient, your risk of infection is low. It is understandable that you may feel anxious about the outbreak. Get the facts from reliable sources to help you accurately determine your risks so that you can take reasonable precautions (see Frequently Asked Questions). Seek guidance from WHO, your healthcare provider, your national public health authority or your employer for accurate information on COVID-19 and whether COVID-19 is circulating where you live. It is important to be informed of the situation and take appropriate measures to protect yourself and your family (see Protection measures for everyone).

If you are in an area where there are cases of COVID-19 you need to take the risk of infection seriously. Follow the advice of WHO and guidance issued by national and local health authorities. For most people, COVID-19 infection will cause mild illness however, it can make some people very ill and, in some people, it can be fatal. Older people, and those with pre-existing medical conditions (such as cardiovascular disease, chronic respiratory disease or diabetes) are at risk for severe disease (See Protection measures for persons who are in or have recently visited (past 14 days) areas where COVID-19 is spreading).